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Background: Approximately 1% of the spermatozoa found in ejaculate of healthy men are aneuploid and this rate
increases in the population of subfertile and infertile men. Moreover, fertilization with these aneuploid sperm can
lead to impaired embryo development. Fluorescent In Situ Hybridization (FISH) is the common cytogenetic tool
used for aneuploidy screening on sperm. However, it is a time-consuming technique and cytogenetic or in vitro
fertilization laboratories cannot routinely use it and face the increasing demand of such analyses before Assisted
Reproductive Techniques (ART). As automation can be a clue for routine practice, this study compares manual and
automated scoring of sperm aneuploidy rates using a Metafer Metasystems® device. The results obtained also
contribute to global data about FISH on sperm cells.
Methods: We recruited 100 men addressed for sperm cryopreservation. They all signed an informed consent to
participate in the study. 29 men were donors or consulted before vasectomy (control group) and 71 were
suffering of Hodgkin’s disease or non Hodgkin lymphoma (patient group). One semen sample was collected for
each patient, analyzed according to WHO criteria and prepared for a triple-color FISH using centromeric probes
for chromosomes 18, X and Y. Automated scoring was performed using a Metafer Metasystems® device.
Results: 507,019 cells were scored. We found a strong concordance between the automated and the manual reading
(d < 0.01 in Bland-Altman test). We also did not find a statistically significant difference between the automated and
the manual reading using Wilcoxon test for total aneuploidy rate (p = 0.06), sex chromosomes disomy (p = 0.33),
chromosome 18 disomy (p = 0.39) and diploidy (p = 0.21). Cumulative rate of total aneuploidy was 0.78% ± 0.212%
for patient group and 0.54% ± 0.15 for control group and among this, sex chromosome XY disomy rate was of
0.54% for patient group and 0.27% for control group.
Conclusion: This study validates the automated reading for FISH on sperm with a Metafer Metasystems® device
and allows its use in a laboratory routine.
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Contexte: Le taux d’aneuploïdies spermatiques est d’environ 1% pour les hommes fertiles et augmente notablement
dans la population des individus infertiles. L’obtention d’une fécondation à partir de ces spermatozoïdes aneuploïdes
peut entrainer des anomalies de développement embryonnaire. L’évaluation des taux d’aneuploïdies est actuellement
possible de façon simple par hybridation in situ fluorescente, toutefois la lecture manuelle des signaux obtenus est
longue et fastidieuse. Les techniques de lecture automatisée des spots fluorescents se sont développées ces dernières
années et sont actuellement de plus en plus utilisées en cytogénétique de routine. L’application de ces techniques aux
spermatozoïdes permettrait donc une évaluation plus régulière des aneuploïdies spermatiques en infertilité. Nous
présentons une étude comparée de la lecture manuelle et de la lecture automatisée en système Metafer Metasystem®
sur un échantillon important de témoins fertiles et de patients à caryotype normal.
Méthode: 100 hommes consultant pour congélation de spermatozoïdes ont été inclus dans l’étude après information et
recueil de leur consentement écrit. Cet échantillon était divisé en 29 donneurs fertiles ou patients consultant avant
vasectomie et 71 patients consultant dans le cadre d’une maladie de Hodgkin ou d’un lymphome non hodgkinien. Un
recueil a été réservé pour l’étude, les paramètres spermatiques ont été analysés selon les recommandations de l’OMS.
Ensuite les taux d’aneuploïdies ont été évalués par FISH pour les chromosomes X, Y et 18 en système à trois couleurs
utilisant des sondes centromériques.
Résultats: 507,019 spermatozoïdes ont été analysés. La concordance entre les deux modes de lecture est forte (d < 0.01
in Bland-Altman test) et aucune différence n’a été observée entre la lecture automatique et manuelle au test de
Wilcoxon (p > 0,05) pour le taux global d’aneuploïdies, les disomies des chromosomes sexuels ou du chromosome 18 et
les diploïdies. Le taux global d’aneuploïdies était de 0.78% ± 0.212% pour les patients et 0.54% ± 0.15 pour les
témoins fertiles et le taux de disomies XY était de 0.54% chez les patients et 0.27% chez les témoins.
Conclusion: Les données présentées dans ce travail permettent de valider une utilisation du lecteur automatisé de
spots Metafer Metasystems® pour l’analyse chromosomique des spermatozoïdes en routine.Background
Infertility is defined as the inability to conceive after one
year of unprotected regular coitus. It concerns one in six
couples [1]. The origin of the infertility remains un-
defined in 15% of the cases. Male factors are involved in
approximately half of the other 85% (associated or not
with a female factor) [2,3]. Many factors can influence
male fertility and genetic abnormalities are involved in
about 15% of the cases [4]. These male genetic defects
are currently divided in single gene disorders (CFTR
gene mutations for instance), Y chromosome deletions
(AZF regions), structural and/or numerical chromosome
abnormalities. Concerning chromosomal abnormalities
origin, approximately 1% of the spermatozoa found in
the ejaculates of healthy men are aneuploid [5]. This rate
increases in the population of subfertile and infertile
men. The development of intracytoplasmic sperm injec-
tion (ICSI) has widened the range of male infertility
treated by intra-couple Assisted Reproductive Techniques
(ART) but raised the problem of an increased risk of
transmitting an aneuploidy to the offspring. Most of the
aneuploid concepti lead to miscarriage but some of them
are viable. About 0.2 of live births are aneuploid concep-
tions [6] and most of them are 13, 18 or 21 trisomies or
dysgonosomy. Sex chromosomes are more prone to non-
disjunction than autosomes [7]. Autosomal trisomies fre-
quently have a maternal origin (95% of chromosome 21trisomy and 93% of chromosome 18 trisomy 18), while sex
chromosomal aneuploidies have a paternal one (100% of
47,XYY, 70-80% of 45,X and 50% of 47,XXY) [8]. Among
the infertile men, sperm aneuploidy rates are higher than,
in the fertile men. This increase has been described for all
the chromosomes, but the most elevated rates are ob-
served for chromosome X, Y, 21 and 22 [9,10].
The Fluorescent In Situ Hybridization (FISH), using
locus specific fluorescent probes, is a common cytogenetic
tool employed for chromosome enumeration. Recent stud-
ies have supported the fact that FISH for aneuploidy
screening on sperm cells should be incorporated as a rou-
tine prognostic test before a first ICSI attempt [11,12].
Therefore, several thousands of spermatozoa are usually
analyzed in order to be able to detect statistically signifi-
cant differences between patients and controls even if they
are low. This procedure, when performed manually by a
trained technician is highly time consuming. Tempest and
collaborators demonstrated that no difference is observed
in aneuploidy rates when scoring 1000 cells or 5000 cells
[13]. We evaluated several years ago, that adhering to strict
scoring criteria and depending on the cell density on the
slides, 3 to 15 hours are needed to enumerate the chromo-
somal content of 5.000 cells for a set of three probes. Even
if the number of analyzed cells is lowered to 1000, when
analyzing infertile patients, the time consumed remains
high, since cell density on the slides is usually low. A good
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technique could be automation. Automated systems are
already used in scoring genetic anomalies in different cells
with a strong concordance between manual and automated
screening results [14-16]. To our knowledge, four recent
prospective pilot studies worked on the comparison be-
tween manual and automated approaches on sperm FISH
[17-20]. They all agreed that the automated counting for
FISH on sperm is a useful evolution but requires further
validation on the different systems.
This study evaluates the reliability of the analytical
method for detection of sperm aneuploidy in 100 sam-
ples by comparing the rates obtained after automatic
reading with a METAFER Metasystems® device to man-
ual reading. It also adds a contribution to global data
about FISH on sperm cells.
Materials and methods
Patients
Between 2003 and 2008, a total of 100 men who were
adressed for sperm donation or cryopreservation before
vasectomy (controls, n = 29) or cryopreservation before
gonadotoxic treatment for lymphoma (patients, n = 71),
were recruited to perform sperm aneuploidy analysis
in a multicenter protocol survey of chemotherapy and
radiotherapy gonadotoxic effects on sperm (GAMATOX
project: PHRC 02011601). The study was approved by the
Ethics Committee of the University Hospital of Toulouse
(Comité de Protection des Personnes Sud-Ouest et Outre
Mer). All patients signed an informed consent to partici-
pate in the study.
Sperm analysis
Semen samples were collected in a sterile container after
masturbation. Liquefaction was obtained after 30 min
at 37°C. Sperm concentration, progressive motility and
round cells concentration were determined according to
WHO criteria [21]. As aneuploidy rates are not signifi-
cantly different in fresh and frozen sperm [22,23], all the
samples were frozen in order to perform the evaluation
of aneuploidy rates altogether at one time. Therefore,
after a 1/0.7 dilution in Sperm Freeze® (FertiPro NV,
Belgium), the remaining sperm was frozen in high secur-
ity straws (CryBioSystem, IMV Technologies, USA) using
an automated procedure and stored in liquid nitrogen.
All the samples were then included in the Research Bio-
bank GERMETHEQUE after a standardized procedure of
anonymization.
FISH procedure
For each patient or control, one straw was thawed at 37°C
for 10 minutes. Samples were washed twice with 5 ml
of PBS 1X and fixed in a methanol/acetic acid (3:1,v/v)
solution. Cells were spread on Superfrost© slides and airdried at room temperature. Sperm head decondensation
was performed in NaOH 1 M solution, followed by two
washes in 2X SSC and dehydration in a 70, 90% and pure
ethanol solution. Samples were then hybridized with
Abbott© Vysis centromeric probes (Abbot Laboratories,
USA) CEP 18 (18p11.1-q11.1, D18Z1, SpectrumAqua),
CEP X (Xp11.1-q11.1, DXZ1, SpectrumGreen) and CEP Y
(Yp11.1-q11.1, DYZ3, SpectrumOrange), according to
the Vysis probes protocol in a HYBrite® system (Abbot
Laboratories, USA). Sperm nuclei were counterstained in
a 0,5 μg/ml Hoechst solution for 3 minutes, washed in
PBS 1X for 3 minutes and mounted with antifade.
Aneuploidy scoring
Two trained technicians blind scored the slides on a
Nikon Eclipse 80i epifluorescence microscope. Chromo-
somal aneuploidies were analyzed simultaneously for chro-
mosomes 18, X and Y with Aqua, FITC and Spectrum
Orange filters. In both situations, strict criteria [19] were
used. Only clearly defined sperm nuclei with a flagella and
containing at least one spot were analyzed and two signals
of the same color were considered as different if they were
the same size and were separated at least by a spot diam-
eter. Since, the whole research protocol had been designed
before data of Tempest and coll [13] were published, ap-
proximately 5000 cells were counted per sample, one half
automatically, the other half manually. We did not modify
the design because it also allowed us to detect statistical
differences in each group (more than 1000 in the manual
and in the automated group, and also between the two op-
erators in the manual group). As it cannot be differenciated
between nullosomic cell or hybridization defect, and most
mososomic concepti are not viable, only disomic or diploid
cells were considered. Each sperm cell was identified as
normal (18,X or 18,Y), disomic for sex chromosomes (18,
X,Y, 18,X,X and 18,Y,Y), disomic for chromosome 18
(18,18,X and 18,18,Y) or diploid (18,18,X,Y, or 18,18,X,X
18,18,Y,Y). All the combinations of spots counted in the
cells during the automatic procedure were manually veri-
fied (using the strict criteria listed above) in the galleries of
images provided by the machine. Each observer who per-
formed either the manual reading or the automated read-
ing and verification procedure evaluated the duration of
the procedure.
Data analysis
Data were treated with R software (version number
2.14.1). Sperm quantitatives parameters observed for con-
trols, Hodgkin (H) patients and non-hodgkin lymphoma
(NHL) patients were compared using the Student-t test.
We used the Bland-Altman test to evaluate the con-
cordance between the automated screening and the
manual reading [24]. The variations between the two
types of reading and inter-operator differences were
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Wilcoxon test was used to determine if a difference exists
between the two types of reading for total aneuploidy,
sex chromosome or chromosome 18 disomy and dip-
loidy. We also used the Pearson’s product–moment cor-
relation test to evaluate the correlation degree between
the two types of reading.
Results
Sperm analysis of our population of patients and con-
trols is presented in Table 1 and revealed a mean sperm
concentration in a normal range of 71.1 millions/ml for
the controls and 58.6 millions/ml for the patients. When
considering Hodgkin-s disease and NHL, mean sperm
count was also normal of 57.8 and 60.9 millions/ml. No
statistical difference was observed between the groups
for this parameter (Controls vs Patients : p-value = 0.29 ;
controls vs Hodgkin: p-value = 0.29 ; controls vs NHL:
p-value = 0.58 ; Hodgkin vs NHL: p-value = 0.85). Sperm
motility was also in a normal range in all the groups and
so was progressive motility too. The values were respect-
ively of 44.3 and 43.9% for controls and patients and
40.8 and 53.0% for Hodgkin and NHL patients. No statis-
tical difference was observed among the groups (controls
vs Hodgkin: p-value = 0.18 ; controls vs NHL: p-value =
0.06, NS ; Hodgkin vs NHL: p-value = 0.30). Sperm vitality
was normal in all the groups (controls: 70.9%, Patients:
60.9%, Hodgkin: 61.6%, NHL: 58.7%) but a significant dif-
ference was observed between controls and both types of
patients (controls vs Hodgkin: p-value = 0.01 ; controls vs
NHL: p-value = 0.02) while not between Hodgkin and
NHL groups (p-value = 0.56).
For aneuploidy scoring, an average of 4,970 sperm was
analyzed per sample, half manually and half with the auto-
mated device, for a total of 507,019 cells: 256,539 manually
and 250,480 automatically.
Using Wilcoxon test, our results did not show a statisti-
cally significant difference between the automatic and man-
ual readings for the total aneuploidy rate (p-value = 0.06),Table 1 Sperm analysis
Controls Patients
Sperm analysis n = 29 Total Hodgkin NHL
n = 71 n = 53 n = 18
Sperm concentration
(106/ml)
mean 71.1 58.62 57.85 60.89
SEM 46.74 38.27 36.43 43.70
Progressive motility mean 44.34 43.92 40.83 53.00
SEM 7.27 10.20 10.20 10.44
Sperm viability mean 70.89 60.90* 61.65* 58.71*
SEM 10.75 12.86 12.86 13.96
Mean value with standard error to the mean (SEM) of sperm parameters for
control and patient groups, and for Hodgkin disease and non-Hodgkin
lymphoma (NHL) groups (*p < 0.05 versus controls).the disomies of sex chromosomes (p-value = 0.33), the diso-
mies of chromosome 18 (p-value = 0.39) and the diploidy
(p-value = 0.21). In addition, no statistically significant
inter-operator difference was found (p-value = 0.34). We
also obtained a good correlation between both readings
(Figure 1) for total aneuploidy rate (R2 = 0.96, p-value <
0.01) using the Pearson’s correlation test.
We found a strong concordance (Figure 2) between the
automated screening (tested method) and the manual
reading (reference method) with the Bland Altman test
(2ssd = 0.13, d = −0.009, NS) for total aneuploidy rates.
We also analyzed the time required to analyze the
slides in both methods. Classifying 2500 cells on good
quality slides lasted a mean time of 3 hours manually vs
one hour by the machine followed by ¾ hours for the
operator to check the images in the gallery. When ana-
lyzing bad quality slides, the required average time was
12 hours manually vs 4 hours by the machine followed
by 3 hours of re-analysis by the operator. We also tried
different techniques of spreading or decondensation
without improvement of bad quality slides. The average
gain provided by the machine was 75% of operator time
when considering that the machine was reading the
slides during the night.
Considering all samples, we obtained a total euploidy
rate of 99.29%, (Table 2) and thus a cumulative rate of
total aneuploidy rate (sex chromosome, chromosome 18
and diploidy) of 0.72%. The sex chromosome disomies
were the most frequently observed and represented 0.5%
of the sperm cells analyzed (0.36% 18,X,Y, 0.07% 18,
X,X, 0.07% 18,Y,Y). The disomy rate of chromosome
18 was 0.12% (0.06% 18,18,X, 0.06% 18,18,Y) and the
diploidy rate was 0.1% (0.06% 18,X,Y, 0.02% 18,X,X;
0.02% 18,Y,Y).
Total aneuploidy rate was statistically different between
controls and both patient groups (Table 3), (controls
vs Hodgkin: t = 4.69, df = 68.13, p-value < 0.01, S ; controls
vs NHL: t = 2.33, df = 22.45, p-value = 0.03, S) and no
difference between Hodgkin and NLH groups (t = 0.01,
df = 21.58, p-value = 0.99, NS) was observed. The mean
rate was of 0.56% for the controls, 0,78% for the patients
and among the patients of 0.78% for the Hodgkin and
0.77% for the NHL groups.
Despite the strict criteria used in scoring, which ex-
cluded most of the round cells from scoring, we also
tested our data for the possible scoring of round cells.
According to meiotic data, round cells could be diploid
cells (premeiotic germ cells or somatic cells) or haploid
post meiotic cells. In order to precise if diploid cells
could be round cells, we looked for a correlation be-
tween the rates of diploid cells and the concentration of
round cells. Wilcoxon test for paired data applied to
these parameters revealed a statistical difference among
these (p-value < 0.01).
Figure 1 Pearson’s correlation rate of total aneuploidy rate (R2 = 0,9489).
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Concerning aneuploidy scoring, the automated results
are consistent with the manual ones and aneuploidy rates
obtained by both methods are comparable for all our
values. These results are in accordance with recent publi-
cations on the subject, using either a Metafer [20] or
other systems (Spot AX system [18,19] or BioImage and
Atto Imaging Vision software [17]). But the largest study
published so far included only 24 samples [19] on a Spot
AX system and our study is now the largest one.
A second point to be discussed is the ability of the ma-
chine to classify the spots in the cells without any error.
Since the automated method was in evaluation, manual
verification of the gallery was done systematically, in order
to avoid any misclassification done by the software. For
good quality slides, the rate of misclassified cells remainedFigure 2 Evaluation of non-inferiority between manual and automate
the paired measures is represented by assigning the average of the two ra
ordinate (d = −0.009; 2SSD = 0,127).low. For bad quality slides, the increase of 3 to 4 fold of
the time needed to manually reclassify the cells attested
of a higher rate of misclassification by the machine.
Thus, in our hands, whatever the parameters of auto-
mated reading we used, the galleries of images needed
to be verified to correct misreadings or eliminate cells
which did not fit the strict criteria mentioned previously.
Despite this quite negative aspect, the use of the machine
was still advantageous since the time devoted to this veri-
fication step, was 3 fold shorter than the manual reading
of the spots even for bad quality slides. Moreover, it was
much easier and convenient for the technician to classify
the galleries than read directly through the microscope.
Our results are thus in accordance with other results
published by Carrel and collaborators on the Metafer
Metasystem® device [20,25].d scoring for total aneuploidy rate by Bland-Altman plot. Each of
tes in abscissa and the difference between the two measurements in
Table 2 Comparison of manual and automated scoring
for all the chromosomes analyzed
Manual Automated Total
18,X 50.16 49.60 49.88
18,Y 49.13 49.68 49.41
Total euploidy rate 99.29 99.28 99.29
18,X,Y 0.36 0.36 0.36
18,X,X 0.07 0.07 0.07
18,Y,Y 0.07 0.06 0.07
Total sex disomy rate 0.50 0.49 0.50
18,18,X 0.06 0.06 0.06
18,18,Y 0.06 0.06 0.06
Total 18 disomy rate 0.12 0.12 0.12
18,18,X,Y 0.06 0.06 0.06
18,18,X,X 0.02 0.02 0.02
18,18,Y,Y 0.02 0.02 0.02
Total diploidy rate 0.10 0.10 0.10
Total aneuploidy rate 0.72 0.71 0.72
The table presents the detailed aneuploidy rates (%) for all the chromosomes
analyzed by manual and automated scoring for all the patients and controls.
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ber of samples per day making the sperm-FISH technique
more accessible. In addition, the software allows data sav-
ing for a future use. Fading of the slides after automated
reading is less important than in manual reading, allowing
several readings of the same slide, which is usually quite
difficult in manual reading. Moreover, relocation of the
cells can be done in case of doubt on a result given by the
controller, which is not possible when reading is manual.
Our study is also the first to obtain a correlation for
diploidy rates between both evaluations. The studies
using automated reading have obtained very heteroge-
neous results in diploidy analysis so far. This can beTable 3 Comparison of total aneuploidy rates among the
control and the patient groups
Controls Patients
Total aneuploidy rate n = 29 Total Hodgkin NHL
n = 71 n = 53 n = 18
Manual mean 0.54 0.78* 0.78* 0.76*
SEM 0.15 0.21 0.18 0.28
Automated mean 0.57 0.78* 0.78* 0.77*
SEM 0.15 0.23 0.21 0.29
Total mean 0.56 0.78* 0.78* 0.77*
SEM 0.15 0.22 0.19 0.29
The table presents the mean value with standard error to the mean (SEM) of
total aneuploidy rate for control and patient groups, and for Hodgkin disease
and non-Hodgkin lymphoma (NHL) groups. (*p < 0.05 versus controls).explained by the lack of statistical power in previous
studies and also by the fact that diploid sperm may be
difficult to identify. Indeed, the diploid sperm head is
usually larger and rounder than a haploid one. Determin-
ing if the cell is a diploid sperm or a diploid round germ
cell present in semen can thus be difficult. When using
strict reading criteria, cells suspected as diploid must
have only one flagella to prevent from analyzing over-
lapped sperms. The sperm head basis must be mor-
phologically normal since a too strong decondensation
modifies the sperm head morphology and prevents from a
correct scoring. For the decondensation step, protocols
differ among publications. The three main processes used
are sodium hydroxide, DTT Tris–HCl or heating. In our
experience, whatever the protocol used, it has no effect on
subsequent results (unpublished data). From this first part
of our study, we can conclude that the automated counting
can be substituted to manual reading.
The second part of our study focused on the analysis
of sperm parameters and aneuploidy rates for lymphoma
patients vs controls. Results observed in the literature
concerning sperm parameters of patients with lymph-
oma differ from one study to another. As O’flaherty
et al. [26], we did not find statistical differences between
controls and patients for sperm concentration and mo-
tility, but another study [27] shows a decrease of these
parameters for lymphoma patients. These discrepancies
can be explained by the following causes: patients re-
cruited for these studies have different basal sperm pa-
rameters, different individual parameters like age or
exposition to environmental toxics or different stages of
the disease. Moreover, some had fever during the disease
that may have impaired their spermatogenesis [28]. Our
results only showed a significant decrease in viability for
both patient groups but the mean viability remained in a
normal range in all the groups.
Concerning the global data on sperm chromosomal
abnormalities, the aneuploidy rates of our controls were
quite consistent with the published results [7,29]. This
study provides for the first time data on sperm aneu-
ploidy in a large cohort of lymphoma patients before
gonadotoxic treatment. Several studies describe a non
significant increase in aneuploidy rates for lymphoma
patients [30-33]. In our study, the rates for our patients
appear significantly higher than those observed for the
controls. Our analysis of a large cohort of patients shows
with a higher statistical power, the increase observed by
others on smaller cohorts. We thus can clearly imply an
impact of the disease itself on sperm aneuploidy rates,
although the mechanism of this phenomenon is yet not
understood. We tested if the increase may be related to
higher aneuploidy rates for oligozoospermic patients in
the lymphoma group. This was not the case, since no
difference in aneuploidy rate was observed according to
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More work has to be done to elucidate the impact of the
pathology on aneuploidy rates.
Conclusion
Validation of automated reading for sperm-FISH is a
major technical breakthrough that allows us to consider
routine use of this technique in case of couples consulting
for infertility problems. To date, the sperm-FISH technique
does not allow sperm selection for In-Vitro Fertilization
with Intra Cytoplasmic Sperm Injection. However, it pro-
vides useful information as an indicator of failure rate. Be-
yond the use of automated spot counters and/or image
analysis systems, it would be appropriate for the next tech-
nical evolution to perform these techniques by flow cytom-
etry. The data acquisition would be faster and the number
of analyzed events more consistent.
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